 | Up a level |
Schoepf, Isabella C; Thorball, Christian W; Ledergerber, Bruno; Kootstra, Neeltje A; Reiss, Peter; Raffenberg, Marieke; Engel, Tanja; Braun, Dominique L; Hasse, Barbara; Thurnheer, Christine; Marzolini, Catia; Seneghini, Marco; Bernasconi, Enos; Cavassini, Matthias; Buvelot, Hélène; Arribas, José R; Kouyos, Roger D; Fellay, Jacques; Günthard, Huldrych F and Tarr, Philip E (2022). Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years. The journal of infectious diseases, 225(9), pp. 1581-1591. Oxford University Press 10.1093/infdis/jiab603
Schorr, Olivier; Blach, Sarah; Thurnheer, Christine; Ruis, Christian; Dufour, Jean-Francois (2022). Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic. PLoS ONE, 17(8), e0272518. Public Library of Science 10.1371/journal.pone.0272518
Schoepf, Isabella C; Thorball, Christian W; Ledergerber, Bruno; Engel, Tanja; Raffenberg, Marieke; Kootstra, Neeltje A; Reiss, Peter; Hasse, Barbara; Marzolini, Catia; Thurnheer, Christine; Seneghini, Marco; Bernasconi, Enos; Cavassini, Matthias; Buvelot, Hélène; Kouyos, Roger; Günthard, Huldrych F; Fellay, Jacques; Tarr, Philip E (2021). Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study. Clinical infectious diseases, 73(9), pp. 1597-1604. The University of Chicago Press 10.1093/cid/ciab521
Matthews, Gail V; Bhagani, Sanjay; Van der Valk, Marc; Rockstroh, Juergen; Feld, Jordan J; Rauch, Andri; Thurnheer, Christine; Bruneau, Julie; Kim, Arthur; Hellard, Margaret; Shaw, David; Gane, Ed; Nelson, Mark; Ingiliz, Patrick; Applegate, Tanya L; Grebely, Jason; Marks, Phillipa; Martinello, Marianne; Petoumenos, Kathy; Dore, Gregory J; ... (2021). Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. Journal of hepatology, 75(4), pp. 829-839. Elsevier 10.1016/j.jhep.2021.04.056
Achermann, Yvonne; Kusejko, Katharina; Auñón, Álvaro; Clauss, Martin; Corvec, Stéphane; Esteban, Jaime; Fernandez-Sampedro, Marta; Ferrari, Matteo Carlo; Gassmann, Natalie; Jent, Philipp; Jost, Bernhard; Kouyos, Roger D; Kramer, Tobias Siegfried; Lora-Tamayo, Jaime; Morand, Philippe C; Benito, Natividad; Pablo-Marcos, Daniel; Patel, Robin; Scanferla, Giulia; Sendi, Parham; ... (2021). The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections. Clinical infectious diseases, 72(12), e1064-e1073. Oxford University Press 10.1093/cid/ciaa1839
Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Battegay, Manuel; Boffi El Amari, Emmanuelle; Dang, Thanh; Egger, Jean-François; Fehr, Jan; Mueller-Garamvögyi, Esther; Parini, Andrea; Schaefer, Stephan C; Schoeni-Affolter, Franziska; Thurnheer, Christine; Tinguely, Marianne; Telenti, Amalio; Rothenberger, Sylvia; Swiss HIV Cohort Study, (2012). Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation. PLoS ONE, 7(2), e32168. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0032168
Rauch, Andri; Nolan, David; Thurnheer, Christine; Fux, Christoph A; Cavassini, Matthias; Chave, Jean-Philippe; Opravil, Milos; Phillips, Elizabeth; Mallal, Simon; Furrer, Hansjakob (2008). Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Antiviral therapy, 13(8), pp. 1019-28. London: International Medical Press
Colombo, Sara; Rauch, Andri; Rotger, Margalida; Fellay, Jacques; Martinez, Raquel; Fux, Christoph; Thurnheer, Christine; Günthard, Huldrych F; Goldstein, David B; Furrer, Hansjakob; Telenti, Amalio (2008). The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir. Journal of infectious diseases, 198(6), pp. 864-7. Cary, N.C.: The University of Chicago Press 10.1086/591184
